Browse
Submit Data
Databases
API
Help

Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

CaSR modulator in neuroblastoma model

ABSTRACT: This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

ORGANISM(S): Mus musculus

SUBMITTER: Carmen de Torres

PROVIDER: E-GEOD-73509 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

ACCESS DATA

Json Xml

Publications

Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens.

Rodríguez-Hernández Carlos J CJ Mateo-Lozano Silvia S García Marta M Casalà Carla C Briansó Ferran F Castrejón Nerea N Rodríguez Eva E Suñol Mariona M Carcaboso Angel M AM Lavarino Cinzia C Mora Jaume J de Torres Carmen C

Oncotarget 20160301 13

The calcium-sensing receptor is a G protein-coupled receptor that exerts cell-type specific functions in numerous tissues and some cancers. We have previously reported that this receptor exhibits tumor suppressor properties in neuroblastoma. We have now assessed cinacalcet, an allosteric activator of the CaSR approved for clinical use, as targeted therapy for this developmental tumor using neuroblastoma cell lines and patient-derived xenografts (PDX) with different MYCN and TP53 status. In vitro ...[more]

PMID: 26893368

Similar Datasets

CaSR modulator in neuroblastoma model [human]

Project description:CaSR modulation inhibits neuroblastoma growth 8 control and 7 samples treated with CaSR allosteric activator

2016-03-30 | E-GEOD-73504 | biostudies-arrayexpress

CaSR modulator in neuroblastoma model [mouse]

Project description:CaSR modulation inhibits neuroblastoma growth 8 control and 8 samples treated with CaSR allosteric activator

2016-03-30 | E-GEOD-73506 | biostudies-arrayexpress

BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways

Project description:Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system, and is the most common solid tumor of infancy. NBs are very heterogeneous, with a clinical course ranging from spontaneous regression to resistance to all current forms of treatment. High-risk patients need intense chemotherapy, and only 30-40% will be cured. Relapsed or metastatic tumors acquire multi-drug resistance, raising the need for alternative treatments. Owing to the diverse mechanisms that are responsible of NB chemoresistance, we aimed to target epigenetic factors that control multiple pathways to bypass therapy resistance. We found that the SWI/SNF-related, matrix-associated, actin- dependent regulator of chromatin, subfamily a, member 4 (SMARCA4/BRG1) was consistently upregulated in advanced stages of NB, with high BRG1 levels being indicative of poor outcome. Loss-of-function experiments in vitro and in vivo showed that BRG1 is essential for the proliferation of NB cells. Furthermore, whole genome transcriptome analysis revealed that BRG1 controls the expression of key elements of oncogenic pathways such as PI3K/AKT and BCL2, which offers a promising new combination therapy for high-risk NB Non-silencing control (NSC) or shBRG1 lentiviral vectors were transduced in the Neuroblastoma cell lines SK-N-BE(2) by triplicate. 48h post-infection, total RNA was extracted

2016-03-01 | E-GEOD-74622 | biostudies-arrayexpress

Expression data from heart muscle of cardiac-specific caspase-3 and -7 knockout and wild type newborn and young mice

Project description:Caspases, proteolytic enzymes involved in cell death could play a role independent of cell death in the developing heart in this datasheet we include the expression data obtained from dissected heart muscle (ventricle) of wild type mice and mice knockout for caspase-3,-7 24 samples. genotypes: wild type and cardiac-specific conditional caspase-3 and -7 KO. Age: 1-2-day-old; 30-day-old (aprox 3 male, 3 female/genotype and age).

2015-12-31 | E-GEOD-63023 | biostudies-arrayexpress

Clarion GO screen assay to assess gene expression responses of human SK-N-SH neuroblastoma cells under control and IL-1B induced conditions in response to herbal extracts of Sage (S. offinicalis) and Chamomile (C. nobile).

Project description:Chronic inflammation plays a critical role in the initiation and development of various human illnesses. The use of steroidal anti-inflammatory drugs (SAIDs) or non-steroidal anti-inflammatory drugs (NSAIDs) is now much more frequent and presents a number of unwanted side effects. For example long- or short-term usage of SAIDs presents multiple negative side effects such as stomach irritation, thinning of the skin, immune defence regression, weight gain and even sometimes a cortico-dependence, and NSAIDs have been linked to a higher risk of strokes, heart attacks, and heart-related deaths. In parallel, there has been renewed interest in alternative medicines and natural therapies and thousands of potential medicinal plants, including sage and chamomile. This study assesses the gene expression responses of human SK-N-SH neuroblastoma cells, pre-treated with aqueous ethanol extracts of sage (Salvia officinalis) or Roman chamomile (Chamaemelum nobile), following 4h or 24h treatment with IL-1B versus control conditions.

2020-10-05 | E-MTAB-9611 | biostudies-arrayexpress

CaSR modulator in neuroblastoma model

Project description:This SuperSeries is composed of the SubSeries listed below.

2016-03-30 | GSE73509 | GEO

Expression data of human neuroblastoma cell lines

Project description:Human neuroblatoma cell lines (N=25) and retinal pigmented epithelium cell lines (N=4) were analyzed for gene expression under untreated/baseline growth conditions. Expression profiling and characterization of a set of Neuroblastoma and retinal pigmented epithelium cell lines

2016-02-19 | E-GEOD-78061 | biostudies-arrayexpress

chromothripsis in neuroblastoma

Project description:RNA-seq for four neuroblastoma samples (Paired-end protocol). Neuroblastoma is a pediatric cancer of the peripheral nervous system in which structural chromosome aberrations are emblematic of aggressive tumors. In this study, we investigated somatic rearrangements in two neuroblastoma cell lines and two primary tumors using paired-end sequencing of mate-pair libraries (SRA accession number ERP001414) and RNA-seq. In one cell line and in the two primary tumors, this approach confirmed the localization of the majority of rearrangements within one or two chromosomes, consistent with the phenomenon of chromothripsis. RNA-seq experiments confirmed expression of several predicted chimeric genes and genes with disrupted exon structure including ALK, NBAS, FHIT, PTPRD and ODZ4. RNA-seq analysis allowed the identification of abnormal transcripts expressed from genomic rearrangements that may be involved in neuroblastoma oncogenesis.

2013-03-03 | E-MTAB-1367 | biostudies-arrayexpress

CaSR modulator in neuroblastoma model [mouse]

Project description:CaSR modulation inhibits neuroblastoma growth

2016-03-30 | GSE73506 | GEO

CaSR modulator in neuroblastoma model [human]

Project description:CaSR modulation inhibits neuroblastoma growth

2016-03-30 | GSE73504 | GEO